Order Article Reprints

de Gruil N, Böhringer S, de Groot S, Pijl H, Kroep JR, Swen JJ. IGF1 and Insulin Receptor Single Nucleotide Variants Associated with Response in HER2-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy with or without a Fasting Mimicking Diet (BOOG 2013-04 DIRECT Trial). Cancers. 2023; 15(24):5872. https://doi.org/10.3390/cancers15245872

de Gruil, Nadia, Stefan Böhringer, Stefanie de Groot, Hanno Pijl, Judith R. Kroep, and Jesse J. Swen. 2023. "IGF1 and Insulin Receptor Single Nucleotide Variants Associated with Response in HER2-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy with or without a Fasting Mimicking Diet (BOOG 2013-04 DIRECT Trial)" Cancers 15, no. 24: 5872. https://doi.org/10.3390/cancers15245872

de Gruil, N., Böhringer, S., de Groot, S., Pijl, H., Kroep, J. R., & Swen, J. J. (2023). IGF1 and Insulin Receptor Single Nucleotide Variants Associated with Response in HER2-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy with or without a Fasting Mimicking Diet (BOOG 2013-04 DIRECT Trial). Cancers, 15(24), 5872. https://doi.org/10.3390/cancers15245872